- Home
- MTEX vs COCP Comparison
MTEX vs COCP Comparison
Compare MTEX & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEX
- COCP
- Stock Information
- Founded
- MTEX 1993
- COCP 2006
- Country
- MTEX United States
- COCP United States
- Employees
- MTEX N/A
- COCP N/A
- Industry
- MTEX Medicinal Chemicals and Botanical Products
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- MTEX Health Care
- COCP Health Care
- Exchange
- MTEX Nasdaq
- COCP Nasdaq
- Market Cap
- MTEX 15.8M
- COCP 15.5M
- IPO Year
- MTEX 1999
- COCP N/A
- Fundamental
- Price
- MTEX $8.50
- COCP $1.57
- Analyst Decision
- MTEX
- COCP Strong Buy
- Analyst Count
- MTEX 0
- COCP 1
- Target Price
- MTEX N/A
- COCP $6.00
- AVG Volume (30 Days)
- MTEX 21.6K
- COCP 171.4K
- Earning Date
- MTEX 08-12-2025
- COCP 08-14-2025
- Dividend Yield
- MTEX N/A
- COCP N/A
- EPS Growth
- MTEX N/A
- COCP N/A
- EPS
- MTEX N/A
- COCP N/A
- Revenue
- MTEX $112,975,000.00
- COCP N/A
- Revenue This Year
- MTEX N/A
- COCP N/A
- Revenue Next Year
- MTEX N/A
- COCP N/A
- P/E Ratio
- MTEX N/A
- COCP N/A
- Revenue Growth
- MTEX N/A
- COCP N/A
- 52 Week Low
- MTEX $7.00
- COCP $1.12
- 52 Week High
- MTEX $16.49
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- MTEX 48.29
- COCP 45.42
- Support Level
- MTEX $7.58
- COCP $1.45
- Resistance Level
- MTEX $10.85
- COCP $1.71
- Average True Range (ATR)
- MTEX 0.96
- COCP 0.10
- MACD
- MTEX 0.02
- COCP -0.02
- Stochastic Oscillator
- MTEX 28.79
- COCP 25.87
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).